"Could this ASX stock become the next Pfizer?"
Hmm, Pfizer hasn't cured a single disease in its history, and it's now facing two class actions in Australia alone.
Talk about a marketing backfire. Who came up with that?
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.48 |
Change
0.000(0.00%) |
Mkt cap ! $260.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1414 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.50 | 4 | 1 |
View Market Depth
| Last trade - 09.25am 28/07/2025 (20 minute delay) ? |
| AFP (ASX) Chart |
Day chart unavailable